Cleo Diagnostics (ASX:COV) Pre-Tax Income : A$ Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cleo Diagnostics's pretax income for the six months ended in Dec. 2023 was A$-2.61 Mil. Cleo Diagnostics does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Dec. 2023. Cleo Diagnostics's pretax margin was %.

Cleo Diagnostics Pre-Tax Income Historical Data

The historical data trend for Cleo Diagnostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Pre-Tax Income Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Pre-Tax Income

-1.73

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Pre-Tax Income	-0.42	-1.31	-2.61

Competitive Comparison of Cleo Diagnostics's Pre-Tax Income

For the Medical Devices subindustry, Cleo Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Pre-Tax Income falls into.

Cleo Diagnostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cleo Diagnostics's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.729	+	0.11	+	-0.111	+	0	+	0
	=	-1.73

Cleo Diagnostics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.782	+	0	+	-0.027	+	0.198	+	0
	=	-2.61

Cleo Diagnostics (ASX:COV) Pre-Tax Income Explanation

Cleo Diagnostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.611	/	0
	=	%

Cleo Diagnostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines